{"name":"Swiss GO Trial Group","slug":"swiss-go-trial-group","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxQaDgyRTZ3dWJPZnNHOEVUTV81UXNjVUZmNHFsVTBicnVaQmlCLWtib1BEWk90dU5fN1ZiRktkdTdtV0pfTGpDWHR0LUZITVBVME9fSzU5S3VJVm00RjUtLXNIamc3cFFQTGk0QVVoOElTSUhwSTRIOHZ1TXBHdmRMNmhBU29HSmJZYzRBNm9QeXYyQ05jblFUMDZmRlY4Wkd1T2dfLUVZaUVkNzJ2Z2hSYUo2ckhRYS1RTThjQXE2d0J2R0U?oc=5","date":"2026-03-09","type":"trial","source":"Reuters","summary":"Roche shares drop as oral breast cancer drug combination fails key trial - Reuters","headline":"Roche shares drop as oral breast cancer drug combination fails key trial","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxPQVJiM3lQaVcyT0NPQy1fNVdYMWxxWnhha0x0c2FRbVZ0S2Z5RkxNRVBQZG85X2M1a3A4eWxYaVNsSGJlYWNZbmxtYU1kQVlBQ3BxamVxcC04XzlLWU4tVnFXX0xaaHVZYXZVdTRBb2JEcUtHbWstUEJQMVdBTm9kUXJEVFdlbzZSZEJLYWRZNGtYd2t2ajFZTkVXVXEtdzNzMWxBVnNEU0JjYUZZdlNRWTY4ajkySkhGZl9CdTlPMjhidw?oc=5","date":"2026-01-29","type":"trial","source":"Fierce Pharma","summary":"As Roche eyes busy 2026, Vabysmo undershoots targets and Tecentriq fails early lung cancer study - Fierce Pharma","headline":"As Roche eyes busy 2026, Vabysmo undershoots targets and Tecentriq fails early lung cancer study","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxOYnFVSm1sRkJzbWt3cnVURVc5cnZhclVGcDZBR2c0dVVVUWd2MmVtX1pBaklZZkNNN0dUNEVfN1JUOUthdy1pS0FVUV96N3oxSVphZEEyYzBGYnduQTYyNEFCSHFEbG83TGRfdE9jUFExNmlNdXBrTWZ0bDFoT201SnByVVU0V1ptUE8wUnJCb1JmNlF1OXNBLWdzOW0xR3dadHZMUm1CSG81bnpkajNrNHJabDR2SlZnY0tfVHU5bVo3OVhyeXprblRkWnkyOE9qMFE?oc=5","date":"2026-01-27","type":"pipeline","source":"Reuters","summary":"Roche obesity drug shows 22.5% weight loss as it seeks to catch up with Lilly, Novo - Reuters","headline":"Roche obesity drug shows 22.5% weight loss as it seeks to catch up with Lilly, Novo","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxOQkxmbk12TjRSRXhEVnFZTGotcy1sUlZsYXdPSTNBeV9BTk40QnJraDBzeHppNGpuR0JLVmk3TV82a0drdXhTdUpGOTgzMk5DbVdlclZYMTQzSzlfelE1eTdwYXpGVXBNMzV6eW05ZjBPLTFTMHF5TUNscEVlTkhqWQ?oc=5","date":"2025-12-19","type":"pipeline","source":"Fierce Biotech","summary":"Fierce Biotech Fundraising Tracker '25: Atavistik adds $120M; Syneron Bio secures new funds - Fierce Biotech","headline":"Fierce Biotech Fundraising Tracker '25: Atavistik adds $120M; Syneron Bio secures new funds","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE9iVUFUYkF6aGt3akxZT0hGaW1LLTVITDlQdFFCYUZkc2IwaDJKSHZpQ1d2VmtPWldraV9yWm9idUZab0xqcWZzdXllQ1BIaF9WUGVxcFJMNWhPakFld2QzRVg2dElTbkZjVjdzcEY3QmtFRG96SzhTT25aMkY?oc=5","date":"2025-12-17","type":"pipeline","source":"Fierce Biotech","summary":"Fierce Biotech Layoff Tracker 2025: Voyager jettisons 30 staffers; Mythic and Areteia shutter - Fierce Biotech","headline":"Fierce Biotech Layoff Tracker 2025: Voyager jettisons 30 staffers; Mythic and Areteia shutter","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxQVVdJVmUtTU53Z2FOYThfOGpJb3dpV2hjT3J5d1hMa184N3c5akplVDBGdU1FOS1ramFDQV9DdjRHWXZJYzhRaUtrZ0ZwQk1iTHBNWmktakw5UWRMTjgtVG85aVNTZ01EZ1BkaXEwQkZVcXlCbF9hcHIyd0tsZEx1bjVoYmNtZWlyWWxkYjZQSmw3aVRHUHQ4NlFhLVhFaVg2bjNWUFRB?oc=5","date":"2025-12-12","type":"regulatory","source":"Fierce Pharma","summary":"Lilly shifts ambition for broader oral SERD label to largest oncology trial in company history - Fierce Pharma","headline":"Lilly shifts ambition for broader oral SERD label to largest oncology trial in company history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxNYkwtUmVWVDJtNWdpTlFJSDJRbGExc1QzUjg4MXQ5SnNGenNoS093VElqb192dFV1UVNyZkxkVWhtSjdDUmVKd2Ruc3ZPZGJVOUVlXzJYXzJEbkducWJ4MFBmejNnV0JpR0xRSHNQQlpNclNxOXIyNWFWX3FrQ3lyRVA2TUtaZnJKMnppVF8xaGFYWHBXenZRUlprS1RkVnZfZlBFZnlINzY0WjQzZW5OV1R5eTJJU0kzSkZrcHdkdw?oc=5","date":"2025-12-07","type":"trial","source":"Genetic Engineering and Biotechnology News","summary":"StockWatch: Cosmo Surges 40% on Baldness Candidate’s Phase III Data - Genetic Engineering and Biotechnology News","headline":"StockWatch: Cosmo Surges 40% on Baldness Candidate’s Phase III Data","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTFBNa0pTM28zMmtaczdsdEw0MS1GRzFBai13Mjd6SS1mZEtVcG8xMVU4OXV6cnh6MUJhdnNjNlZQdGJ4cUpfSUMwNWdUVUx1bVZKandRbkt1S00zYjlkVFNXal9aMGFQS2dHUXFJcG56MzhzU1hpcXc?oc=5","date":"2025-11-12","type":"pipeline","source":"Labiotech.eu","summary":"19 swiss biotech startups you’ll want to keep an eye on - Labiotech.eu","headline":"19 swiss biotech startups you’ll want to keep an eye on","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxPYzQtZXF5enB1b3J3S1V5SXctcnhYcENHYlpMR1JqSVJvMXpmVTRwZnRvZkRBbmYzTjlwRmVJSHJWcFJvTk5yWkl0RE1QLW4xaVJkM2tuMFNRVzRlQ3ZNR2pyemVvU2R0V2ZsRnIwMGhTNGxUT2hkTk52am9ETzFXd3o0b3Z4a2U4QlZsSWViZWhVSjM0alJZNkstbmRPNW1EM2g5bjEtR1A3MG8?oc=5","date":"2025-09-29","type":"trial","source":"BioPharma Dive","summary":"Moonlake shares crash on mixed study results for immune drug - BioPharma Dive","headline":"Moonlake shares crash on mixed study results for immune drug","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-07-11","type":"pipeline","source":"cnbc.com","summary":"Trump's 200% tariff threat leaves pharma firms scrambling with scenario planning - cnbc.com","headline":"Trump's 200% tariff threat leaves pharma firms scrambling with scenario planning","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxNTTRhRW03bWEyc3ZOMkRsS05UeW1VUXNyV1l4dGxwSE4xM2FZNm50RFk0RjVxSWpqcm5WTHp3MDFJMFZCblp6TU9sWngyZTczbjkzdjM2b3VuSC1xOFM2VVlhMFM4RXJmN1RndlVHekhNZnUtWFkyQUs0WDdwaTVfbEdnZ2s1VHhFU0IxRmpWR2tZeEhQaUJxSnFNVjVPbVZGeUREdzh5dlFvbm9rRUoyajBNdVUyQQ?oc=5","date":"2025-04-22","type":"pipeline","source":"AP News","summary":"Swiss pharmaceuticals company Roche announces $50B investment in US over next 5 years - AP News","headline":"Swiss pharmaceuticals company Roche announces $50B investment in US over next 5 years","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5jUWI0SC12aWNtMXFIVERtOE81LVFZd2VTZWFrZjNSSU9NYnF3anpFZlFCMmlaQ3FleUQ5TG9VZTdRQ1BFejloZWtBWXFEQjJJd1A1bGk2MTUzMDFtWEFKNUlwQnBuYjNEa0FOelR3?oc=5","date":"2024-10-23","type":"trial","source":"Oncology Pipeline","summary":"Not so B-Fast for Roche | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline","headline":"Not so B-Fast for Roche | ApexOnco - Clinical Trials news and analysis","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}